http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2485502-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_012f065c77f545bed249d428c7518478 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate | 2012-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b86e554574d4502e07bb538233019e26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c766bec5b3d08653fd9e9f38a0cc703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27a65cb7c735774d82b88f042a2ccf96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de8d70705450f8ec2b7f0b3fd4e855c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5775bccb5e785c5bb79d6af34b33305f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e676c019abf8d2a43c5d65489e094830 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4b925e3fa16ebdb9390b774c7f7f579 |
| publicationDate | 2013-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2485502-C1 |
| titleOfInvention | Method for assessing morphofunctional status of human thrombocytes |
| abstract | FIELD: medicine. n SUBSTANCE: sampled blood, or plasma, or thrombocyte concentrate is stained in a micro-tube with tripaflavine and acridine orange, and a fluorescence microscope is used to count thrombocyte granules, to measure a light intensity of 100-200 vitally stained cells; the light intensities are summed and divided on the thrombocyte count examined to calculate an average thrombocyte light intensity to be expressed in foot-candles per 1 cell relevant to one point characterising morphofunctional thrombocyte activity (MFAT). Further, the preparation with vitally stained thrombocytes is placed in a thermostat; a fluorescence microscope is used to count by spread-eagle thrombocytes with projecting granules, divided by total cell count analysed and expressed in %, wherein one percent is relevant to one point characterising thrombocyte adhesive activity (TAA). Then total MFAT and TAAT show the morphofunctional status of thrombocytes. n EFFECT: method provides an objective assessment of the morphofunctional status of human thrombocytes. n 6 dwg, 6 tbl, 3 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2623073-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2623074-C1 |
| priorityDate | 2012-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.